PP
BSTC

PDT Partners’s BioSpecifics Technologies Corp. BSTC Stock Holding History

PDT Partners’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,500
Closed -$218K – 490
2019
Q1 		$218K Buy
+3,500
New +$232K 0.01% 383
2015
Q2 		– Sell
-5,800
Closed -$227K – 1752
2015
Q1 		$227K Buy
+5,800
New +$227K 0.01% 1238

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's BSTC Position: Q2 2019 in Review

PDT Partners sold out of BioSpecifics Technologies Corp. (BSTC) in Q2 2019, closing a stake of 3,500 shares — an estimated $218K sold.

PDT Partners first reported a position in BSTC in Q1 2015 and held it in 2 quarters. The position peaked at $227K in Q1 2015. 114 funds tracked by Wall St. Rank hold BSTC as of Q2 2019.

  • PDT Partners reported no remaining BioSpecifics Technologies Corp. position as of Q2 2019 after selling out during the quarter.
  • PDT Partners sold 3,500 BioSpecifics Technologies Corp. shares in Q2 2019, an estimated $218K.
  • PDT Partners first reported a position in BioSpecifics Technologies Corp. in Q1 2015 and held it in 2 quarters.
  • PDT Partners's BioSpecifics Technologies Corp. position peaked at $227K in Q1 2015.
  • 114 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q2 2019.

Based on PDT Partners's 13F filing for Q2 2019, filed 14 Aug 2019.